Auswahl der wissenschaftlichen Literatur zum Thema „Pregnancy Complications“

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Pregnancy Complications" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Pregnancy Complications"

1

Kochar Kaur, Kulvinder. „Endometriosis and Pregnancy - Associated Complications“. Open Access Journal of Gynecology 3, Nr. 3 (2018): 1–2. http://dx.doi.org/10.23880/oajg-16000164.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Abdallah A.MA. „Pregnancy complications“. World Journal of Advanced Research and Reviews 20, Nr. 3 (30.12.2023): 703–8. http://dx.doi.org/10.30574/wjarr.2023.20.3.2526.

Der volle Inhalt der Quelle
Annotation:
A normal pregnancy is generally considered to be a healthy and uncomplicated pregnancy. It typically lasts around 40 weeks and is divided into three trimesters. During a normal pregnancy, the fertilized egg implants in the lining of the uterus, and the baby develops and grows inside the uterus. Throughout the pregnancy, there are several important milestones and changes that occur. These include regular prenatal check-ups, monitoring the baby's growth, and ensuring the mother's overall health. Common symptoms during pregnancy may include nausea or morning sickness, fatigue, increased urination, breast tenderness, and mood swings.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Aslam Ahsan, Dr Muhammad, und Dr Muhammad Rafique Cheema. „PREGNANCY; THROMBOEMBOLIC COMPLICATIONS“. PROFESSIONAL MEDICAL JOURNAL 23, Nr. 03 (01.03.2016): 284–87. http://dx.doi.org/10.17957/tpmj/16.2952.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

NYBERG, DAVID A., LAURENCE A. MACK, FAYE C. LAlNG und R. BROOKE JEFFREY. „Early Pregnancy Complications“. Obstetrical & Gynecological Survey 44, Nr. 2 (Februar 1989): 108–11. http://dx.doi.org/10.1097/00006254-198902000-00005.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Gnanasambanthan, Sai, und Shree Datta. „Early pregnancy complications“. Obstetrics, Gynaecology & Reproductive Medicine 29, Nr. 2 (Februar 2019): 29–35. http://dx.doi.org/10.1016/j.ogrm.2018.12.011.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Haq, Abiyyu Didar, Cut Warnaini, Muhammad Rizkinov Jumsa und Deasy Irawati. „Pregnancy-related Complications in Relation with Delivery Complication in Urban Public Health Center in 2019-2020: an Analytic Comparative Study“. Journal of Community Empowerment for Health 6, Nr. 2 (28.08.2023): 93. http://dx.doi.org/10.22146/jcoemph.77441.

Der volle Inhalt der Quelle
Annotation:
With a huge gap of knowledge and understanding created by the current pandemic especially in regards to maternal health, this research aimed to compare and analyze the correlation between pregnancy-related complication with delivery complication in an urban public health center before and during the pandemic. This is an analytic comparative study utilizing retrospective cohort approach. Medical records of pregnant women during 2019-2020 were obtained from Pagesangan public health center with approved ethics from Mataram University and related government agencies. Collected data were then analyzed for each year and then compared between 2019 and 2020 to see if there any significant differences between maternal health before and during the COVID-19 pandemic. Medical records of 653 pregnant women were collected in this study. 22 of 311 and 27 of 342 pregnancy-related complications were recorded in 2019 and 2020, respectively. While 68 of 311 and 70 of 342 delivery complications were recoded in 2019 and 2020, respectively. Analysis was done to obtain the relative risk (RR) of each year and then we compared the obtained RR of both year. In 2019, the RR of pregnany-related complication to delivery complication was 0,398 (95% CI 0,104-1,518) while in 2020 the obtained RR was 0,522 (95% CI 0,176-1,550). Pregnancy-related complications were not the risk factor of delivery complications in both year. However, a significant correlation was found between maternal age and pregnancy-related complication in 2020 while in 2019, gravidity was also found significantly related with delivery complications.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Murugaboopathi, Sindhuja, und Hephzibah Kirubamani. „Awareness of Complications of First Trimester Pregnancy“. Indian Journal of Obstetrics and Gynecology 7, Nr. 4 (P-2) (2019): 627–31. http://dx.doi.org/10.21088/ijog.2321.1636.7419.9.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

VK, Sita, und N. Hephzibah Kirubamani. „Awareness on Complications of Fever in Early Pregnancy“. Indian Journal of Obstetrics and Gynecology 7, Nr. 3 (P-2) (2019): 487–93. http://dx.doi.org/10.21088/ijog.2321.1636.7319.20.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Junagam, Sreeman N., und Balu Jatthavath. „EVALUATION OF LIVER ENZYMES IN PREGNANCY WITH COMPLICATIONS“. International Journal of Integrative Medical Sciences 5, Nr. 6 (05.07.2018): 659–62. http://dx.doi.org/10.16965/ijims.2018.119.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

., Akansha, und Nagajan Bhadarka. „Incidence of early pregnancy complications, management protocols and its outcome in patients at Gujarat Adani Institute of Medical Science, Bhuj, Kutch, Gujarat, India“. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, Nr. 9 (28.08.2017): 3837. http://dx.doi.org/10.18203/2320-1770.ijrcog20173667.

Der volle Inhalt der Quelle
Annotation:
Background: Early Pregnancy Complications can cause significant morbidity and mortality. Pregnant women an present with h/o amenorrhea, abdominal pain, vaginal bleeding or incidental scan finding of missed abortion, ectopic pregnancy and vesicular mole, features of hypermesis gravidorum like fatigue, nausea, vomiting, dryness and diminished urine output. The objective of present study was to analyze the incidence of various early pregnancy complications, assess the protocols for diagnosing these complications and their management.Methods: Present study was conducted at the Department of Obstetrics and Gynecology, Gujarat Adani Institute of Medical Science, Bhuj, Kutch, Gujarat. All the women with first trimester pregnancy with different complications were included in this study while those women with uneventful first trimester were excluded. The inducted women were registered on pre-designed proforma. Studied variables including demographic details, gestational period, type of complications, risk factors, treatment and outcome.Results: Out of 740 total admissions 439 abortions of which incomplete abortion was 262, missed abortions were 132, threatened abortion 42 and 3 cases of septic abortion, ectopic pregnancy 154, molar pregnancy33, hyperemesis 31. There were about 63 cases of non-pregnancy related complication reported during early pregnancy like 31 with UTI, 9 with renal colic, 2 cases of appendicitis, four cases of asymptomatic cholelithiasis, 2 cases of hepatitis, 5 cases of ovarian cyst complicating pregnancy, 2 cases of ovarian torsion. Their mean age was 30.8+6.8 years.Conclusions: Study was successful in creating a confidence among trainees when following the recommended protocols as well as delivering clinical benefits to the hospital, patients and staff. Early gynecological consultation and bedside ultrasound scanning within the emergency department were key requirements for any emergency concerns.
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Dissertationen zum Thema "Pregnancy Complications"

1

Benton, Samantha Jayne. „Angiogenic factors in placentally-mediated pregnancy complications“. Thesis, University of British Columbia, 2014. http://hdl.handle.net/2429/50014.

Der volle Inhalt der Quelle
Annotation:
Placentally-mediated pregnancy complications include pre-eclampsia, intrauterine growth restriction (IUGR), placental abruption and some causes of stillbirth. These complications are believed to arise from abnormal placental development in early gestation that leads to compromised placental function in later pregnancy which can adversely affect both mother and fetus. It is a priority in obstetrics to identify these pregnancies early and accurately so that appropriate monitoring and intervention can optimise outcomes for these mothers and babies. Novel biomarkers such as angiogenic factors in the maternal circulation may improve the prediction and/or diagnosis of these complications by adding to the information gained from tools already used in clinical practice. In this thesis, I investigated angiogenic factors in 1) the diagnosis of pre-eclampsia using new clinical immunoassays, 2) the prediction of placentally-mediated complications in a high-risk pregnancy cohort and 3) the diagnosis of placental IUGR in pregnancies with small for gestational age (SGA) fetuses. Additionally, I investigated the association between levels of circulating angiogenic factors and the presence of histopathological lesions of dysfunction in the placenta after delivery. I found that angiogenic factors, particularly low circulating placental growth factor (PlGF), had high sensitivity and specificity in the diagnosis of pre-eclampsia but all markers had poor performance as predictive markers for placentally-mediated complications. In pregnancies with SGA fetuses, low maternal PlGF discriminated between fetuses with placental IUGR (defined by the presence of histological lesions of placental dysfunction) from constitutionally small fetuses (no pathological lesions present) with high sensitivity and high negative predictive value. Additionally, low maternal PlGF in the second trimester was associated with the presence of lesions of placental dysfunction in pregnancies at high-risk for placentally-mediated complications. Low maternal PlGF was also associated with lesions of placental dysfunction as well as altered placental morphology in pregnancies with SGA fetuses. Taken together, these findings suggest that PlGF may be an antenatal marker of placental dysfunction and may provide a novel clinical tool to identify pregnancies with placental dysfunction. This work improves our understanding of angiogenic factors in placentally-mediated complications and contributes to the growing body of evidence supporting their integration in clinical practice.
Medicine, Faculty of
Obstetrics and Gynaecology, Department of
Graduate
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

ElMoursi, Mohamed Saad Elsayed. „Quantification of placental dysfunction in pregnancy complications“. Thesis, University of Leeds, 2017. http://etheses.whiterose.ac.uk/17262/.

Der volle Inhalt der Quelle
Annotation:
Background The pathogenetic mechanisms behind placental dysfunction-related complications like preeclampsia and intrauterine growth restriction have remained perplexing till now, in part because of lack of well-defined structural and functional molecular characterisation. There is growing evidence that links trophoblast debris and the existence of syncytial nuclear aggregates (SNA) to the pathogenesis of gestational diseases. Characterisation and quantification of structural and functional parameters of placental dysfunction may give researchers a clearer picture of the mechanisms underlying the development of high risk pregnancy. Methods Placental samples were obtained from normal term pregnancies, preterm controls, as well as from pregnancies complicated by preeclampsia (PET), intrauterine growth restriction (IUGR) and PET-IUGR. Formalin-fixed, paraffin-embedded sections were visualised with H&E, stained using immunohistochemistry (IHC) and digitally scanned. Using stereological methodology, volumes of placental SNAs, trophoblasts, villi and capillaries were measured. Three dimensional (3D) volume reconstructions of terminal placental villi with SNAs and fibrinoid degenerations were created. IHC-labelled slides were analysed by image analysis algorithms. Differential expression of placental genes and miRNAs, hypothesised to regulate cell death in placental dysfunction, were quantified using RT-qPCR. BeWo cell lines were carried out for in vitro validation of the effects miRNAs regulating programmed cell death (PCD) using flow cytometry and western blotting. Results Specific morphometric patterns of villous, trophoblasts, SNA and capillary volumes were demonstrated with characteristic higher SNAs and lower capillary volumes in PET placentae with reciprocal patterns in IUGR placentae showing a negative correlation pattern between nuclear aggregates and capillary volumes. Image analysis of immune-labelled slides showed a higher autophagy marker expression in PET and a positive correlation to SNAs as well as a balanced reciprocal expression patterns with apoptosis. Moreover, miR-204 transfected BeWo cells showed a similar balanced reciprocal regulation of autophagy and apoptosis expressions. Conclusion We have demonstrated that applying stereology-based and image analysis on digitised placental sections can be useful in quantifying and dissecting structural and functional patterns in normal and abnormal placental function. 3D reconstruction model are a novel approach towards placental characterisation in normal and complicated pregnancies. The study also showed that miR-204 plays a vital role in the regulation of placental autophagy and apoptosis, critical in the pathophysiology of placental dysfunction.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Rodie, Vanessa Angela. „Metabolic complications of pregnancy and cardiovascular disease risk“. Thesis, University of Glasgow, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.421118.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Demetriou, Charalambos. „Investigating genetic factors associated with complications of pregnancy“. Thesis, Imperial College London, 2014. http://hdl.handle.net/10044/1/30728.

Der volle Inhalt der Quelle
Annotation:
This PhD project sets out to investigate the role of genetic factors associated with fetal growth restriction and recurrent miscarriage (RM), two of the most common complications of pregnancy. This work studied large cohorts of patients collected from specialist clinics in West London with the aim of better understanding their underlying molecular aetiology. The first part of this project focused on the paternally expressed, maternally imprinted gene, IGF2, which is a key growth hormone critical for in utero growth in mice. Its role in human fetal growth has remained ambiguous, as it has only been studied in term tissues. mRNA expression levels of IGF2 and other genes were investigated in 260 chorionic villus samples collected at 11-13 weeks' gestation. Transcript levels of IGF2 revealed a significant positive correlation with birth weight (P=0.009). Critically, small for gestational age neonates had significantly lower IGF2 levels than appropriate for gestational age neonates (P=3.6x10-7). Next a study was undertaken to investigate a potential role for disturbed imprinting in products of conception (POC). This work first involved a detailed analysis of the POC DNA to establish levels of maternal cell contamination. POCs could then be more accurately evaluated to investigate the status of known imprinted genes. Interestingly, in a number of POCs, known maternally expressed genes were found to be paternally expressed and vice versa. This suggested that some miscarriages might be associated with or even caused by abnormal imprinting. Two approaches were then used to study genetic factors associated with RM. The first involved a genetic association study with a placental anti-coagulant protein Annexin A5 that contains four nucleotide substitutions (M2 haplotype) in its promoter. Patient and control haplotypes were determined and compared in 500 White European pairs that had RMs and 250 control trios. Carriers of the M2 haplotype were found to exhibit higher RM risk than non-carriers, which was in agreement with previous studies. However, this is only true for the patients who suffered with early miscarriages. The second study involved analysis of a single family where the patient had experienced a total of 29 miscarriages but had no successful pregnancies. Next-generation exome sequencing was carried on family members to search for a potential rare genetic variant gene causative of the RM phenotype. Two candidate genes with potentially damaging mutations were investigated in more depth by sequencing them in cohorts of Asian RM patients (n=100) and White European RM patients (n=120). In one of the genes, three novel variants and one very rare SNP, which were all predicted to be damaging by different prediction programs, were identified in a total of four Asian patients. Future studies to further investigate these potential mutations, involves functional analysis of each variant such as site-directed mutagenesis and protein-protein interactions.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Bayingana, Claude. „The prevalence of members of the "red complex" in pregnant women as revealed by PCR and BANA hydrolysis“. Thesis, University of the Western Cape, 2005. http://etd.uwc.ac.za/index.php?module=etd&amp.

Der volle Inhalt der Quelle
Annotation:
Increased levels of oestrogen and progesterone during pregnancy may lead to periodontal disease. The anaerobic Gram-negative bacteria called red complex (Porphyromonas gingivalis, Tannerella forsythensis and Treponema denticola) are frequently associated with periodontal disease. Periodontopathogens produce toxins and enzymes which can enter the bloodstream and cross the placenta to harm the foetus. The response of the mother&rsquo
s immune system to infection by these periodontopathogens, brings about the release of inflammatory mediators which may trigger preterm labour or result in low birth-weight infants. The purpose of this study was to examine the prevalence of red complex, using BANA and PCR in subginginval plaque samples from pregnant women. Subgingival plaque samples were obtained from pregnant women between the ages of 17 to 45 years attending a Mitchells Plain ante-natal clinic. Plaque samples were analyzed by the enzymatic BANA-test for detection of the presence of red complex and DNA was extracted and analyzed using 16 rDNA-Polymerase Chain Reaction (PCR).

Seventy-nine percent of pregnant women showed gingival index scores of &ge
1 of which 74.24% harboured by at least one of the members of the red complex. P.gingivalis was the most prevalent of the three members of the red complex. Findings of this study confirmed a need for dental preventive measures in pregnant women and microbial monitoring of suspected periodontopathogenes. This could be achieved by joint cooperation between Maternity Obstetric Units (MOU), Dentistry and oral microbiology departments. The results of this study revealed that although PCR is more sensitive than BANA in detecting members of the red complex, BANA showed a better association with the indices used to diagnose periodontal disease.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Björklund, Anders. „Hypoglycaemia in pregnancy : hypoglycaemic clamp studies during and after pregnancy in women with IDDM /“. Stockholm, 1998. http://diss.kib.ki.se/search/diss.se.cfm?19980605bjor.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Wilkerson, Diana Sue. „Perinatal complications as predictors of infantile autism“. Virtual Press, 1992. http://liblink.bsu.edu/uhtbin/catkey/833467.

Der volle Inhalt der Quelle
Annotation:
This study investigated the impact of perinatal complications on the developing child and the relationship of those complications to the development of autism in an individual. The biological mothers of autistic children (N = 183) completed the Maternal Perinatal Scale, a maternal selfreport which surveys complications of pregnancy and medical conditions of the mother. Archival data on normals (N = 209), obtained during previous perinatal investigations, was utilized as a control group.Previous research in this area has been limited, with no definitive conclusions. All previous investigators have declined to state that events identified in previous research were definitely related to the development of autism.An overall multivariate test was performed to determine if significant differences existed between the autistic and normal subjects. Following this exploration of the data, previously identified complications were entered into a stepwise discriminant analysis in the order of theirtheoretical importance to determine the extent of their contribution to autism. Following this analysis, medical conditions of the mothers (items 27-47 as included on the MPS) were entered into the stepwise analysis to determine their contribution, if any, to autism in the sample.The results of this analysis revealed that the two groups differed significantly on three of the ten factors of the MPS. The overall multivariate test was highly significant and revealed that the groups differed on Factor 2 (Gestational Age), Factor 4 (Maternal Morphology), and Factor 8 (Intrauterine Stress). Moreover, five of the six previously identified items were found to be significant. These were: prescriptions raken during pregnancy, length of labor, viral infection,, abnormal presentation at delivery, and low birthweight. Three of the maternal medical conditions examined were also highly significant and contributed to separation between groups. These were: urinary infection, high temperatures, and depression. These were items which have not been identified in previous investigations.Based on discriminant analysis of the 10 factors of the MPS, 65% of the cases were correctly grouped. The MPS would be a useful clinical tool in identification of those children who are at risk for development of autism.
Department of Educational Psychology
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Walker, Kate Frances. „Late pregnancy complications in women of advanced maternal age“. Thesis, University of Nottingham, 2016. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.718852.

Der volle Inhalt der Quelle
Annotation:
The age of childbearing is rising in women living in industrialised nations. Advanced maternal age is associated with a small increased risk of term antepartum stillbirth. Labour induction would likely reduce stillbirth, but might also increase Caesarean delivery, already high for older women. The aim of this thesis was to design and conduct a randomised controlled trial of induction of labour at 39 weeks versus expectant management for nulliparous women aged over 35 years. In total 619 women participated and the trial showed that induction of labour has no adverse short-term effects on maternal or neonatal outcomes. In particular, it does not increase caesarean section rate. A cost-utility analysis of the trial was performed and demonstrated that induction of labour is associated with a small gain in QALYs and is not more expensive than expectant management. One key secondary outcome of the trial was maternal satisfaction. There is a lack of a robust validated tool for evaluating labour experience in the UK therefore a study of 350 women was performed to validate a Swedish instrument (Childbirth Experience Questionnaire) in the UK. This study demonstrates that the Childbirth Experience Questionnaire is a valid and reliable measure of childbirth experience in the UK population. A study examining the causes of 2850 cases of antepartum stillbirth in women of advanced maternal age using anonymised national data found that stillbirths in women over 35 years old are more likely to be due to major congenital anomalies, mechanical causes, maternal disorders or associated obstetric factors than women less than 35. In 2013, a systematic review of randomised controlled trials of induction of labour versus expectant management at term found that a policy of induction was associated with a 17% reduction in the risk of caesarean section. An IPD meta-analysis of induction of labour versus expectant management at term in women with intact membranes by subgroups of maternal age has shown that induction in women of advanced maternal age has no statistically significant effect on caesarean section rates.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Syngelaki, Argyro. „Screening for pregnancy complications at 11-13 weeks' gestation“. Thesis, Manchester Metropolitan University, 2015. http://e-space.mmu.ac.uk/595938/.

Der volle Inhalt der Quelle
Annotation:
Background: The current approach to prenatal care, which was established more than 80 years ago, is characterised by a high concentration of visits in the third-trimester of pregnancy which implies that firstly, most complications occur at this late stage of pregnancy and secondly, most adverse outcomes are unpredictable during the first or even the second trimester. Objectives: The objective of this thesis is to provide evidence that most pregnancy complications are predictable as early as 12 weeks’ gestation. The pregnancy complications examined include fetal aneuploidies, fetal structural defects, preeclampsia, preterm birth, gestational diabetes mellitus and fetal macrosomia. Methods: I have critically examined fourteen articles reporting on screening for pregnancy complications at 11-13 weeks’ gestation, where more than 90,000 singleton pregnancies were prospectively assessed at 11-13 weeks’ gestation as part of a routine prenatal visit for screening for trisomy 21. We recorded a series of maternal characteristics and history, measured maternal weight and height, performed a detailed ultrasound examination of the fetus, measured maternal uterine artery Doppler pulsatility index and maternal mean arterial pressure and collected blood for analysis of biomarkers for prospective or retrospective analysis. All data were prospectively entered into our data base as well as the pregnancy outcomes as soon as they became available. Ethical approval was obtained for these studies. Multivariate regression analysis was used to define the contribution of each maternal characteristic and history in predicting each adverse outcome and those with a significant contribution formed an algorithm to estimate the background risk (a priori risk) for each one of these complications. The potential value of biophysical and biochemical markers in improving the performance of the a priori risk in predicting adverse pregnancy outcomes, was evaluated. Results: First trimester effective screening for adverse pregnancy outcomes was provided by a combination of maternal factors and biophysical or biochemical markers. The developed predictive models could correctly identify the vast majority of aneuploidies, early preeclampsia and more than half of the cases of spontaneous preterm birth and gestational diabetes. First trimester prediction of fetal macrosomia was less effective compared with other complications. First trimester examination of fetal anatomy was feasible resulting in a high detection of fetal non-chromosomal defects, including more than half of fetal cardiac defects. Conclusions: Assessment of the mother and fetus at 11-13 weeks’ gestation can provide effective early identification of the high risk group of pregnancies with fetal and maternal adverse outcomes.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Chaudhry, Shazia Hira. „The Association of Homocysteine with Placenta-Mediated Pregnancy Complications“. Thesis, Université d'Ottawa / University of Ottawa, 2019. http://hdl.handle.net/10393/39425.

Der volle Inhalt der Quelle
Annotation:
Background: Preeclampsia, small for gestational age (SGA), placental abruption, and fetal death are pregnancy complications linked to the utero-placental vasculature with serious consequences for maternal and infant well-being. Elevated homocysteine, a marker of cardiovascular disease risk, is postulated to play a role in placenta-mediated complications, but epidemiologic studies have reported inconsistent findings. The two primary objectives of this thesis were to 1: comprehensively investigate the association of homocysteine with placenta-mediated complications and examine modifying effects of pre-specified factors on this association, and 2: comprehensively investigate determinants of maternal homocysteine during pregnancy. Methods: A systematic review and meta-analysis of prospective studies was conducted to address thesis objective 1. The Ottawa and Kingston (OaK) Birth Cohort, a prospective cohort study that recruited pregnant women between 2002 and 2009, was used to address thesis objectives 1 and 2. Homocysteine concentration was measured between 12 and 20 weeks gestation. Analyses based on the OaK Birth Cohort consisted of multivariable regressions using restricted cubic splines to model associations with continuously distributed variables. Results: Objective 1: In an analysis of 7587 participants, a significant association between homocysteine concentration and a composite outcome of any placenta-mediated complication was observed (odds ratio (OR) for a 5 µmol/L increase: 1.63, 95% Confidence Interval (CI) 1.23-2.16) and SGA (OR 1.76, 95% CI 1.25-2.46), with potential modifying effects of the methylene tetrahydrofolate reductase (MTHFR) 677C>T variant (SGA) and high-risk pregnancy (preeclampsia). In the systematic review identifying 30 prospective cohort or nested case-control studies, a random effects meta-analysis of pooled mean differences in homocysteine between cases and controls in 28 studies revealed significantly higher means for SGA: 0.35 µmol/L (95% CI 0.19 to 0.51, I2=33%); and preeclampsia: 0.87 µmol/L (95% CI 0.52 to 1.21, I2=92%). Significant sources of heterogeneity were study region (SGA and preeclampsia), adjusting for covariates (preeclampsia), folate status (preeclampsia), and severity (preeclampsia). Objective 2: In 7587 OaK participants, factors related to favourable health status were associated with lower maternal homocysteine concentrations. Folic acid supplementation during pregnancy of >1 mg/day did not substantially increase serum folate concentration. Conclusion: This thesis suggests an independent effect of slightly higher homocysteine concentration in the early to mid-second trimester on the risk of any placenta-mediated complication, SGA, and preeclampsia. Modifying effects explain some of the variability in previous studies. Favourable preconception health status was associated with lower maternal homocysteine.
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bücher zum Thema "Pregnancy Complications"

1

N, Canfield Richard, Hrsg. Infectious pregnancy complications. Hauppauge, NY: Nova Science Publishers, 2009.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Peeters, L. L. H., P. W. de Leeuw und E. D. Post Uiterweer. Pathophysiology of pregnancy complications. Houten: Bohn Stafleu van Loghum, 2021. http://dx.doi.org/10.1007/978-90-368-2571-9.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

1933-, Burrow Gerard N., und Duffy Thomas P, Hrsg. Medical complications during pregnancy. 5. Aufl. Philadelphia: W.B. Saunders Co., 1999.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

1933-, Burrow Gerard N., Duffy Thomas P und Copel Joshua A, Hrsg. Medical complications during pregnancy. 6. Aufl. Philadelphia: Elsevier Saunders, 2004.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Roberts, William E. Medical complications during pregnancy. Philadelphia, PA: W.B. Saunders, 1992.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

E, Roberts William, Hrsg. Medical complications during pregnancy. Philadelphia: Saunders, 1992.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

S, Yerby Mark, und Devinsky Orrin, Hrsg. Neurologic complications of pregnancy. Philadelphia: Saunders, 1994.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

1933-, Burrow Gerard N., und Ferris Thomas F. 1930-, Hrsg. Medical complications during pregnancy. 3. Aufl. Philadelphia: Saunders, 1988.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

1933-, Burrow Gerard N., und Ferris Thomas F. 1930-, Hrsg. Medical complications during pregnancy. 3. Aufl. Philadelphia: Saunders, 1988.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

D, Craigo Sabrina, und Baker Emily R, Hrsg. Medical complications in pregnancy. New York: McGraw-Hill, 2005.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Buchteile zum Thema "Pregnancy Complications"

1

Roy, Deblina. „Pregnancy Complications“. In Encyclopedia of Evolutionary Psychological Science, 1–8. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-16999-6_730-1.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Roy, Deblina. „Pregnancy Complications“. In Encyclopedia of Evolutionary Psychological Science, 6128–35. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-319-19650-3_730.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Lefebvre, Cedric W., Jay P. Babich, James H. Grendell, James H. Grendell, John E. Heffner, Ronan Thibault, Claude Pichard et al. „Pregnancy, Infectious Complications“. In Encyclopedia of Intensive Care Medicine, 1803–15. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_93.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Mathiesen, Elisabeth R., Lene Ringholm und Peter Damm. „Complications in Pregnancy“. In A Practical Manual of Diabetes in Pregnancy, 257–68. Chichester, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119043805.ch20.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Palomba, Stefano, und Bart C. J. M. Fauser. „Complications of Pregnancy“. In Infertility in Women with Polycystic Ovary Syndrome, 305–23. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-45534-1_22.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Dewey, Kayla, Kathryn Voss und Carolyn Phillips. „Early Pregnancy Complications“. In Emergency Department Management of Obstetric Complications, 1–14. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-54410-6_1.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Pat, Susan. „Ectopic Pregnancy and Complications of Pregnancy“. In When Doctors Get Sick, 413–17. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4899-2001-0_46.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Quinlan, Jeffrey D. „Obstetric Complications During Pregnancy“. In Family Medicine, 165–76. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-04414-9_13.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Davison, John M., Adrian I. Katz und Marshall D. Lindheimer. „Renal Complications of Pregnancy“. In Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS, 561–603. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4757-6632-5_35.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Smith, Mindy A., und Judith A. Suess. „Obstetric Complications During Pregnancy“. In Family Medicine, 106–21. New York, NY: Springer New York, 1998. http://dx.doi.org/10.1007/978-1-4757-2947-4_13.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Pregnancy Complications"

1

Farah, Huda Mohamed, Muram Elmubarak Elamin, Rahaf Nader Nader Nader, Rana Said Alabsi, Salma Bouazza Bouabidi, Sara Elgaili Khogali Suleiman, Shahd Mohammad Nasr, Shouq Fahad Al-Rumaihi, Zain Zaki Zakaria und Maha alasmakh Alasmakh. „Metagenomic Analysis of Oral Microbiome during pregnancy“. In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0135.

Der volle Inhalt der Quelle
Annotation:
Pregnancy is a dynamic physiological process associated with significant hormonal, immune and metabolic changes to support the growth and development of the fetus. Several studies have highlighted the role of gut microbiota during pregnancy1. The composition of gut microbiota changes dramatically during the course of pregnancy with an increase in Proteobacteria and Actinobacteria, a decline in butyrate-producing bacteria and a reduction in bacterial richness at the end of pregnancy2. These modifications were anticipated to favour the increased metabolic demand during pregnancy, which will, in turn, support healthy fetal growth3. Gut microbiota has also been suggested to contribute to weight gain during pregnancy via increased absorption of glucose and fatty acids, induction of catabolic pathways, increased fasting-induced adipocyte factor secretion, and stimulation of the immune system2, 4. The oral cavity houses the second most diverse microbiota after the gut harbouring over 700 species of bacteria. Oral microbiota plays a crucial role in maintaining oral homeostasis, protecting the oral cavity and preventing disease development5. Little is known about the role of the oral microbiome during pregnancy. One study examined changes in oral microbiota during pregnancy on Japanese women and found that the total viable microbial counts were higher during pregnancy, as were levels of the pathogenic bacteria Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Candida6. Several studies have also found correlations between oral infections and pregnancy complications, further suggesting mechanisms connecting the oral microbiome with the state of pregnancy7. The Qatari Birth Cohort (QbiC) was successfully developed in July 2018 by Qatar Biobank. It is an epidemiological study that aims to assess the synergetic role of environmental exposure and genetic factors in the development of chronic disease. It monitors the health of women throughout their pregnancy and after birth. The present study is designed to explore changes in the salivary microbiome, using high throughput sequencing during pregnancy and to explore key microbial clades involved in pregnancy.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Tagieva, F. A. „On the risk of pregnancy complications“. In General question of world science. "Science of Russia", 2019. http://dx.doi.org/10.18411/gq-31-07-2019-35.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Schmitt, S., T. Meller, F. Stein, K. Brosch, S. Meinert, D. Grotegerd, U. Dannlowski, A. Krug, I. Nenadíc und T. Kirchner. „The impact from complications of pregnancy on gyrification“. In Abstracts of the 2nd Symposium of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) and Deutsche Gesellschaft für Biologische Psychiatrie (DGBP). Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0039-3403026.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Verdezoto, Nervo, Francisca Carpio-Arias, Valeria Carpio-Arias, Nicola Mackintosh, Parisa Eslambolchilar, Verónica Delgado, Catherine Andrade und Galo Vásconez. „Indigenous Women Managing Pregnancy Complications in Rural Ecuador“. In NordiCHI '20: Shaping Experiences, Shaping Society. New York, NY, USA: ACM, 2020. http://dx.doi.org/10.1145/3419249.3420141.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Konnaiyan, Karthik Raj, Surya Cheemalapati, Anna Pyayt und Michael Gubanov. „mHealth dipstick analyzer for monitoring of pregnancy complications“. In 2016 IEEE SENSORS. IEEE, 2016. http://dx.doi.org/10.1109/icsens.2016.7808968.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Bartkeviciute, A., und D. Bartkevičienė. „P217 The impact of Ureaplasma infections on pregnancy complications“. In Abstracts for the STI & HIV World Congress, July 14–17 2021. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/sextrans-2021-sti.304.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Marin, Iuliana, und Nicolae Goga. „LEARNING ANALYTICS SOFTWARE FOR MEDICAL STUDENTS REGARDING PREGNANCY COMPLICATIONS“. In 13th International Technology, Education and Development Conference. IATED, 2019. http://dx.doi.org/10.21125/inted.2019.0870.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

„Trans-biobank genome-wide association analysis of pregnancy complications“. In Bioinformatics of Genome Regulation and Structure/Systems Biology (BGRS/SB-2022) :. Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences, 2022. http://dx.doi.org/10.18699/sbb-2022-225.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Korneeva, Inna, Kristina Kramar, Evgeniia Semenova und Zafar Yuldashev. „A System for Remote Monitoring of Pregnant Women's Health State and Pregnancy Complications Prediction“. In Special Session on Remote Management and Health Monitoring. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011011500003123.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Cabral, Brenda Cristyanne Silva, Isabela Cristina Maioni Xavier, Giovana Souza Oliveira, Jade Fleury Toccafondo, Maria Carolina Boeira Keller, Bárbara Natiely Bezerra Andrade, Caroline Gomes dos Santos et al. „Relationship between the dimensions of eating behavior and weight gain in high-risk pregnant women monitored at a university hospital“. In V Seven International Multidisciplinary Congress. Seven Congress, 2024. http://dx.doi.org/10.56238/sevenvmulti2024-158.

Der volle Inhalt der Quelle
Annotation:
During the gestational period, several physiological adaptations occur in the woman's body to meet the demands of the maternal-fetal binomial and childbirth. These changes encompass anatomical, hormonal, metabolic and immunological aspects, varying according to gestational age. After confirmation of pregnancy, it is essential that the woman begins prenatal care in Basic Health Units (UBS), although cases of risk factors may require follow-up in highly complex hospitals. Several factors, such as individual characteristics, previous and obstetric conditions, can make a pregnancy high-risk, requiring lifestyle changes and professional support to avoid adverse outcomes. Inadequate weight gain during pregnancy is one of these factors, associated with complications such as gestational diabetes, high blood pressure and childhood obesity. The prevalence of overweight and obesity among pregnant women has increased, highlighting the importance of adequate monitoring during pregnancy for maternal and fetal health.
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Berichte der Organisationen zum Thema "Pregnancy Complications"

1

Brännström, Mats, Ylva Carlsson und Henrik Hagberg. Obstetric outcome after uterus transplantation. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Januar 2023. http://dx.doi.org/10.37766/inplasy2023.1.0052.

Der volle Inhalt der Quelle
Annotation:
Review question / Objective: Is delivery by elective cesarean section as safe for the mother and the neonate after uterus transplantation as after delivery by elective cesarean section for reasons such as breech and psychological indication regarding stillbirth/neonatal mortality, neonatal morbidity, maternal mortality, and morbidity? Rationale: To compare pregnancy, obstetrical and neonatal complications at delivery by cesarean section in patients that have undergone uterus transplantation and in a normal groups of women.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Huntington, Dale. Meeting women's health care needs after abortion. Population Council, 2000. http://dx.doi.org/10.31899/rh2000.1036.

Der volle Inhalt der Quelle
Annotation:
Women who seek emergency treatment for abortion complications—bleeding, infection, and injuries to the reproductive tract system—should be a priority group for reproductive health care programs. These women often receive poor-quality services that do not address their multiple health needs. They may be discharged without counseling on postoperative recuperation, family planning (FP), or other reproductive health (RH) issues. Women who have had an induced abortion due to an unwanted pregnancy are likely to have a repeat abortion unless they receive appropriate FP counseling and services. Preventing repeat unsafe abortions is important for RH programs because it saves women's lives, protects women’s health, and reduces the need for costly emergency services for abortion complications. At the 1994 International Conference on Population and Development, the world's governments called for improvements in postabortion medical services. As part of the resulting international postabortion care initiative, the Population Council’s Operations Research and Technical Assistance projects worked collaboratively to conduct research on interventions to improve postabortion care. This brief summarizes the major findings of this research and relevant studies by other international organizations.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Foreit, James R. Postabortion family planning benefits clients and providers. Population Council, 2005. http://dx.doi.org/10.31899/rh16.1006.

Der volle Inhalt der Quelle
Annotation:
A woman’s fertility can return quickly following an abortion or miscarriage, yet recent data show high levels of unmet need for family planning (FP) among women who have been treated for incomplete abortion. This leaves many women at risk of another unintended pregnancy and in some cases subsequent repeated abortions and abortion-related complications. It is thus vital for programs to provide a comprehensive package of postabortion care (PAC) services that includes medical treatment, FP counseling and services, and other reproductive health services such as evaluation and treatment for sexually transmitted infections, HIV counseling and/or testing, and community support and mobilization. Providing FP services within PAC benefits clients and programs. Facilities that can effectively treat women with incomplete abortions can also provide contraceptive services, including counseling and appropriate methods. As stated in this brief, any provider who can treat incomplete abortion can also provide selected FP methods. Clients, providers, and programs benefit when FP methods are provided to postabortion clients at the time of treatment.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Saldanha, Ian J., Gaelen P. Adam, Ghid Kanaan, Michael L. Zahradnik, Dale W. Steele, Valery A. Danilack, Alex Friedman Peahl, Kenneth K. Chen, Alison M. Stuebe und Ethan M. Balk. Postpartum Care up to 1 Year After Pregnancy: A Systematic Review and Meta-Analysis. Agency for Healthcare Research and Quality (AHRQ), Juni 2023. http://dx.doi.org/10.23970/ahrqepccer261.

Der volle Inhalt der Quelle
Annotation:
Objectives. This systematic review assesses postpartum care for individuals up to 1 year after pregnancy. We addressed two Key Questions (KQs) related to the comparative effectiveness and harms of: (1) alternative strategies for postpartum healthcare delivery and (2) extension of postpartum health insurance coverage. Data sources and review methods. We searched Medline®, Embase®, Cochrane CENTRAL, CINAHL®, and ClinicalTrials.gov from inception to November 16, 2022, to identify comparative studies in the United States and Canada (for KQ 1) and in the United States (for KQ 2). We extracted study data into the Systematic Review Data Repository Plus (SRDR+; https://srdrplus.ahrq.gov). We assessed the risk of bias and evaluated the strength of evidence (SoE) using standard methods. The protocol was registered in PROSPERO (registration number CRD42022309756). Results. We included 50 randomized controlled trials (RCTs) and 14 nonrandomized comparative studies (NRCSs) for KQ 1 and 28 NRCSs for KQ 2. Risk of bias was moderate to high for most RCTs and all NRCSs. KQ 1: Regarding where healthcare is provided, for general postpartum care (6 studies), whether the visit is at home/by telephone or at the clinic may not impact depression or anxiety symptoms (low SoE). For breastfeeding care (8 studies), whether the initial visit is at home or at the pediatric clinic may not impact depression symptoms up to 6 months postpartum, anxiety symptoms up to 2 months, hospital readmission up to 3 months (summary relative risk [RR] 1.38, 95% confidence interval [CI] 0.90 to 2.13; 4 studies), or other unplanned care utilization up to 2 months (low SoE, all outcomes). Regarding how care is provided, for general postpartum care (4 studies), integration of care (i.e., care provided by multiple types of providers) may not impact depression symptoms or substance use up to 1 year (low SoE). Regarding when care is provided, for contraceptive care (9 studies), compared with later contraception, earlier contraception start is probably associated with comparable continued IUD use at 3 and 6 months but greater implant use at 6 months (summary RR 1.36, 95% CI 1.13 to 1.64; 2 RCTs) (moderate SoE). Regarding who provides care, for breastfeeding care (19 studies), compared with no peer support, peer support is probably associated with higher rates of any breastfeeding at 1 month (summary effect size [ES] 1.13, 95% CI 1.03 to 1.24; 4 studies) and 3 to 6 months (summary ES 1.22, 95% CI 1.06 to 1.41; 4 studies) and of exclusive breastfeeding at 1 month (summary ES 1.10, 95% CI 1.02 to 1.19; 6 studies) but probably yields comparable rates of exclusive breastfeeding at 3 months and nonexclusive breastfeeding at 1 and 3 months (all moderate SoE). Compared with no lactation consultant, breastfeeding care by a lactation consultant is probably associated with higher rates of any breastfeeding at 6 months (summary ES 1.43, 95% CI 1.07 to 1.91; 3 studies) but not at 1 month or 3 months (all moderate SoE). Lactation consultant care may not be associated with rates of exclusive breastfeeding at 1 or 3 months (moderate SoE). Regarding coordination/management of care, provision of reminders for testing is probably associated with greater adherence to oral glucose tolerance testing up to 1 year postpartum but not random glucose testing or hemoglobin A1c testing (moderate SoE). Regarding use of information or communication technology (IT; 8 studies), IT use for breastfeeding care is probably associated with comparable rates of any breastfeeding at 3 months and 6 months and of exclusive breastfeeding at 3 months (all moderate SoE). Because of sparse evidence, inconsistent results, and/or the lack of reporting of prioritized outcomes, no conclusions related to interventions targeting healthcare providers are feasible (4 studies). KQ 2: Regarding health insurance (28 studies), more comprehensive health insurance is probably associated with greater attendance at postpartum visits (moderate SoE) and may be associated with fewer preventable readmissions and emergency room visits (low SoE). Conclusion. Most studies included in this systematic review enrolled predominantly healthy postpartum individuals. Researchers should therefore design studies that, either entirely or in part, enroll individuals at high risk of postpartum complications due to chronic conditions, pregnancy-related conditions, or incident or newly diagnosed conditions. New high-quality research is needed, especially for interventions targeting healthcare providers and the impact of more comprehensive or extended health insurance on postpartum health. Patient-reported outcomes, such as quality of life, should also be reported. Researchers should report separate data for various population subgroups, which could help close gaps in health outcomes among the races of postpartum individuals in the United States.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Seme, Assefa, Solomon Shiferaw, Ayanaw Amogne, Anna Popinchalk, Leilena Shimeles, Ephrem Berhanu, Ricardo Mimbela und Margaret Giorgio. Impact of the COVID-19 Pandemic on Adolescent Sexual and Reproductive Health in Ethiopia. Guttmacher Institute, November 2021. http://dx.doi.org/10.1363/2021.33198.

Der volle Inhalt der Quelle
Annotation:
Key Points The COVID-19 pandemic and its associated restrictions raised concerns that adolescents in Ethiopia may face reduced access to youth-friendly sexual and reproductive health services. Public and private service statistics data reveal that from March through the end of 2020, the COVID-19 pandemic had at least a short-term impact on adolescent sexual and reproductive health outcomes. The COVID-19 pandemic is estimated to have resulted in an annualized increase of: 20,738 adolescents with an unmet need for contraception 8,884 unintended pregnancies among adolescents Approximately 10.1 million Ethiopian birr (more than US$250,000) in costs for the Ethiopian health system for pregnancy-related and newborn care 438 adolescent women with major obstetric complications 14 adolescent maternal deaths Ethiopia’s Ministry of Health and private health providers could take several steps to ensure that access to sexual and reproductive health services for adolescents continues throughout the remainder of the COVID-19 pandemic: Adopt an emergency response plan that addresses adolescents’ sexual and reproductive health needs Support health care workers, particularly health extension workers, to increase access to contraceptives for adolescents Engage adolescents at all levels of the Ministry of Health decision-making process Support the expansion of youth-friendly services across regions with additional staff and resources
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Cao, Xianling, Xuanyou Zhou, Naixin Xu, Songchang Chang und Chenming Xu. Association of IL-4 and IL-10 Polymorphisms with Preterm Birth Susceptibility: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0044.

Der volle Inhalt der Quelle
Annotation:
Review question / Objective: The aim of our systematic review and meta-analysis was to summarize the effects of IL-4 and IL-10 gene polymorphism and clarify their possible association with PTB. Condition being studied: World Health Organization (WHO) defines preterm birth (PTB) as babies born alive before 37 weeks of pregnancy are completed. The new estimates show that the prevalence of PTB during 2014 ranged from 8.7% to13.4% of all live births, about 15 million preterm babies born each year. Besides, PTB is the leading cause of death worldwide for children below 5 years of age. Babies born preterm are at an increased risk of short-term and long-term complications attributed to immaturity of multiple organ systems, such as cerebral palsy, intellectual disabilities, vision and hearing impairments, and impaired cognitive development. PTB has become a worldwide public health problem, but its etiology remains unclear. Accumulating evidence shows that PTB is a syndrome that can be attributed to a variety of pathological processes(5). Inflammatory diseases and genetic background are known risk factors for PTB, many studies had shown that genetic variations in proinflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-1 α (IL-1 α) are associated with increased risk of PTB, but the relationship between genetic polymorphism in anti-inflammatory cytokines and risk of PTB remains controversial.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Jamlick, Karumbi. Do emergency obstetric referral interventions reduce maternal and neonatal mortalities in low- and middle-income countries? SUPPORT, 2016. http://dx.doi.org/10.30846/1608123.

Der volle Inhalt der Quelle
Annotation:
Ensuring access to healthcare by pregnant women is a challenge in low- and middle-income countries. Even if access is possible, a lack of adequate personnel or equipment may mean that complications cannot be treated when they arise. Emergency referral interventions have been advocated to reduce both maternal and neonatal mortality.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Feng, Zhichao, Zhimin Yan und Qianyun Liu. MRI Signs for Prenatal Prediction of Placenta Accreta Spectrum Disorders and Invasiveness in High-risk Pregnant Women: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0003.

Der volle Inhalt der Quelle
Annotation:
Review question / Objective: This meta-analysis aimed to identify the significant MRI signs for placenta accreta spectrum in high-risk pregnant women and to determine their diagnostic value. Condition being studied: Placenta accreta spectrum (PAS) is a dangerous complication in pregnancies with increasing incidence worldwide, in which the villous tissue adheres or invades the uterine wall. Eligibility criteria: Articles assessing the diagnostic performance of MRI signs for PAS and/or placenta percreta in high-risk pregnant women underwent full-text review. Included studies required confirmation of diagnosis based on intraoperative and/or pathologic findings.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Rosen, Michael, C. Matthew Stewart, Hadi Kharrazi, Ritu Sharma, Montrell Vass, Allen Zhang und Eric B. Bass. Potential Harms Resulting From Patient-Clinician Real-Time Clinical Encounters Using Video-based Telehealth: A Rapid Evidence Review. Agency for Healthcare Research and Quality (AHRQ), September 2023. http://dx.doi.org/10.23970/ahrqepc_mhs4telehealth.

Der volle Inhalt der Quelle
Annotation:
Objectives. To review the evidence on harms associated with patient-clinician real time encounters using video-based telehealth and determine the effectiveness of any related patient safety practices (PSPs). PSPs are interventions, strategies, or approaches intended to prevent or mitigate unintended consequences of healthcare delivery and improve patient safety. This review provides information that clinicians and health system leaders need to determine how to minimize harms from increasing real-time use of telehealth. Methods. We followed rapid review processes of the Agency for Healthcare Research and Quality Evidence-based Practice Center Program. We searched PubMed, EMBASE, and Cochrane to identify eligible studies published from 2012 to 2022, supplemented by a search for unpublished evaluations and white papers. Outcomes of interest included: adverse events (any harm to patients due to medical care), other specified harms (i.e., preventable hospitalizations, inappropriate treatment, missed or delayed diagnoses, duplication of services, privacy breaches), and implementation factors for any PSPs. Findings. Our search retrieved 7,155 citations, of which 23 studies (including 6 randomized controlled trials [RCTs]) were eligible for review. Fourteen studies reported on adverse events or unintended effects of telehealth; these studies were conducted in diverse settings, with four studies in behavioral health, two each in rehabilitation, transplant, and Parkinson’s care, and one each in postoperative, termination of pregnancy, community health, and hospital-at-home settings. Adverse events such as death, reoperation, infection, or major complications were infrequent in both telehealth and usual care groups, making it difficult to find statistically significant differences. One RCT found telehealth resulted in fewer medication errors than standard care. Thirteen studies examined preventable hospitalizations or emergency department (ED) visits and reported mixed findings; six of these studies were in postoperative care and two were in urological care. Of the 6 RCTs, 3 showed no difference in risk of hospitalization or ED visits for telehealth compared to usual care, and 3 showed reduced risk for patients receiving telehealth. We found no studies on the effectiveness of PSPs in reducing harms associated with real-time telehealth. Conclusions. Studies have evaluated the frequency and severity of harms associated with real-time video-based telehealth encounters between clinicians and patients, examining a variety of patient safety measures. Telehealth was not inferior to usual care in terms of hospitalizations or ED visits. No studies evaluated a specific PSP. More research is needed to improve understanding of harms associated with real-time use of telehealth and how to prevent or mitigate those harms.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Lee, Yi-Chieh, Yun-Chen Chang und Hsueh-Yu Li. The effect of continuous positive airway pressure treatment on the reduction of gestational complications in pregnant women with obstructive sleep apnea. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, März 2024. http://dx.doi.org/10.37766/inplasy2024.3.0013.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie